2D (2 Dimensional) TEQR design for Determining the optimal Dose for safety and efficacy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

2D (2 Dimensional) TEQR design for Determining the optimal Dose for safety and efficacy

Published:2019-12 Issue: Volume:16 Page:100461
ISSN:2451-8654
Container-title:Contemporary Clinical Trials Communications
language:en
Short-container-title:Contemporary Clinical Trials Communications

Author:

Ananthakrishnan Revathi^ORCID,Green Stephanie,Li Daniel,LaValley Michael

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference34 articles.

1. Continual reassessment method: a practical design for phase 1 clinical trials in cancer;O'Quigley;Biometrics,1990

2. The continual reassessment method for dose-finding studies: a tutorial;Garrett-Mayer;Clin. Trials,2006

3. A modified toxicity probability interval method for dose-finding trials;Ji;Clin. Trials,2010

4. Toxicity equivalence range design (TEQR): a practical Phase I design;Blanchard;Contemp. Clin. Trials,2011

5. Dose finding with escalation with overdose control (EWOC) in cancer clinical trials;Tighiouart;Stat. Sci.,2010

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy-Driven Dose Finding with Toxicity Control in Phase I Oncology Studies;Statistics in Biosciences;2021-10-23

2. Chimeric antigen receptor T‐cell therapies: Optimising the dose;British Journal of Clinical Pharmacology;2020-03-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP